Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen

✍ Scribed by Hideaki Kishimoto; Masao Fukunaga; Kazuhiro Kushida; Masataka Shiraki; Akira Itabashi; Hajime Nawata; Toshitaka Nakamura; Hiroaki Ohta; Kunio Takaoka; Yasuo Ohashi

• Publisher: Springer
• Year: 2006
• Tongue: English
• Weight: 183 KB
• Volume: 24
• Category: Article
• ISSN: 0914-8779
• DOI: 10.1007/s00774-006-0706-z